Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line

Biology of Reproduction

Volumn 73, Issue 1, 2005, Pages 172-179

  Fukushima, Kotaro ^a   Miyamoto, Shingo ^a   Tsukimori, Kiyomi ^a   Kobayashi, Hiroaki ^a   Seki, Hiroyuki ^b   Takeda, Satoru ^b   Kensuke, Egashira ^a   Ohtani, Kishio ^a   Shibuya, Masabumi ^c   Nakano, Hitoo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cytokines; Early development; Placenta; Pregnancy; Trophoblast

Indexed keywords

ALPHA1 INTEGRIN; ALPHA6 INTEGRIN; BETA3 INTEGRIN; CD51 ANTIGEN; INTEGRIN; MATRIGEL; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CAPILLARY; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TROPHOBLAST;

APOPTOSIS; CELL COUNT; CELL DIFFERENTIATION; CELL LINE; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FEMALE; HUMANS; INTEGRIN ALPHA CHAINS; INTEGRIN BETA CHAINS; LAMININ; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; PROTEINS; PROTEOGLYCANS; TRANSFECTION; TROPHOBLASTS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 20844455123     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.104.039479     Document Type: Article

References (40)

1. Vicovac L, Aplin JD. Epithelial-mesenchymal transition during trophoblast differentiation. Acta Anat 1996; 156:202-216.
2. Brosens IA, Robertson WB, Dixon HG. The role of spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1:177-191.
3. Damsky CH, Fitzgerald ML, Fisher SJ. Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest 1992; 89:210-222.
4. Damsky CH, Librach C, Lim KH, Fitzgerald ML, McMaster MT, Janatpour M, Zhou Y, Logan SK, Fisher SJ. Integrin switching regulates normal trophoblast invasion. Development 1994; 120:3657-3666.
5. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblast cells. J Clin Invest 1993; 91:950-960.
6. Lim KH, Zhou Y, Janatpour M, McMaster M, Bass K, Chun SH, Fisher SJ. Human cytotrophoblast differentiation/invasion is abnormal in preeclampsia. Am J Pathol 1997; 151:1809-1818.
7. Fukushima K, Miyamoto S, Komatsu H, Tsukimori K, Kobayashi H, Takeda S, Seki H, Nakano H. TNFalpha-induced apoptosis and integrin switching in human extravillous trophoblast cell line. Biol Reprod 2003; 68:1771-1778.
8. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999; 285: 1028-1032.
9. Eliceiri BP, Cheresh DA. Role of alpha v integrins during angiogenesis. Cancer J 2000; 6:245-249.
10. Hynes RO. A reevaluation of integrins as regulators of angiogenesis. Nat Med 2002; 8:918-921.
11. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M, Damsky CH. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 1997; 99:2139-2151.
12. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997; 99:2152-2164.
13. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct 2001; 26:25-35.
14. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407:249-257.
15. Witmer AN, van Blijswijk BC, van Noorden CJ, Vrensen GF, Schlingemann RO. In vivo angiogenic phenotype of endothelial cells and pericytes induced by vascular endothelial growth factor-A. J Histochem Cytochem 2004; 52:39-52.
16. Lewis MP, Clements M, Takeda S, Kirby PL, Seki H, Lonsdale LB, Sullivan MH, Elder MG, White JO. Partial characterization of an immortalized human trophoblast cell-line, TCL1, which possesses a CSF-1 autocrine loop. Placenta 1996; 17:137-146.
17. Bishof P, Friedli E, Martelli M, Campana A. Expression of extracellular matrix-degrading metalloproteinases by cultured human cytotrophoblast cells: effects of cell adhesion and immunopurification Am J Obstet Gynecol 1991; 165:1791-1801.
18. Librach CL, Werb Z, Whitzgerald ML, Chiu K, Corwin NM, Esteves RA, Gronvery D, Galardy R, Damsky CH, Fisher SJ. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991; 113:437-449.
19. Kohler PO, Bridson WE. Isolation of hormone-producing clonal lines of human choriocarcinoma. J Clin Endocrinol 1971; 32:683-687.
20. Ohtani K, Egashira K, Hiasa K, Zhao Q, Kitamoto S, Ishibashi M, Usui M, Inoue S, Yonemitsu Y, Sueishi K, Sata M, Shibuya M, Sunagawa K. Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells. Circulation 2004; 110:2444-2452.
21. Townsend PA, Villanova I, Uhlmann E, Peyman A, Knolle J, Baron R, Teti A, Horton MA. An antisense oligonucleotide targeting the alphaV integrin gene inhibits adhesion and induces apoptosis in breast cancer cells. Eur J Cancer 2000; 36:397-409.
22. Zapolska-Downar D, Zapolski-Downar A, Markiewski M, Ciechanowicz A, Kaczmarczyk M, Naruszewicz M. Selective inhibition by probucol of vascular cell adhesion molecule-1 (VCAM-1) expression in human vascular endothelial cells. Atherosclerosis 2001; 155:123-130.
23. Motomura S, Fukushima K, Nishitani H, Nawata H, Nishimoto T. A hamster temperature sensitive G1 mutant, tsBN250, has a single point mutation in histidyl-tRNA synthetase that inhibits an accumulation of cyclin D1. Genes Cells 1996; 1:1101-1112.
24. Kendall RL, Wang G, Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT1, and its heterodimerization with KDR. Biochem Biophys Res Commun 1996; 226:324-328.
25. Gutheil JC, Campbell TN, Pierce PR, Watkins JD, Huse WD, Bodkin DJ, Cheresh DA. Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin αVβ3. Clin Cancer Res 2000; 6:3056-3061.
26. Genbacev O, DiFederico E, McMaster M, Fisher SJ. Invasive cytotrophoblast apoptosis in preeclampsia. Hum Reprod 1999; 14:56-66.
27. Levy R, Nelson DM. To be, or not to be, that is the question. Apoptosis in human trophoblasts. Placenta 2000; 21:1-13.
28. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002; 160:1405-1423.
29. Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 2004; 95:884-891.
30. Charnock-Jones DS, Sharkey AM, Boocock CA, Ahmed A, Plevin R, Ferrara N, Smith SK. Localization and activation of the receptor for vascular endothelial growth factor on human trophoblast and choriocarcinoma cells. Biol Reprod 1994; 51:524-530.
31. Vuckovic M, Ponting J, Terman BI, Niketic V, Seif MW, Kumar S. Expression of vascular endothelial growth factor receptor, KDR, in human placenta. J Anat 1996; 188:361-366.
32. Hamai Y, Fujii T, Yamashita T, Nishina H, Kozuma S, Mikami Y, Taketani Y. Evidence for an elevation in serum interleukin 2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 1997; 38:89-93.
33. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EAH, Martin JN, Bennett WA. Expression of the placental cytokines tumor necrosis factor a, interleukin 1β and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999; 181:915-920.
34. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2000; 11:372-377.
35. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, Kuwano M. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 1997; 17:4015-4023.
36. Ko Y, Totzke G, Gouni-Berthold I, Sachinidis A, Vetter H. Cytokine-inducible growth factor gene expression in human umbilical endothelial cells. Mol Cell Probes 1999; 13:203-211.
37. Regnaulta TRH, Galanb HL, Parkera TA, Anthonya RV. Placental development in normal and compromised pregnancies - a review. Placenta 2002; 23:5119-5129.
38. Chung IB, Yelian FD, Zaher FM, Gonik B, Evans MI, Diamond MP, Svinarich DM. Expression and regulation of vascular endothelial growth factor in a first trimester trophoblast cell line. Placenta 2000; 21:320-324.
39. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997; 18:657-665.
40. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science 1997; 277:1669-1672.